Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(24):2009-2017; doi:10.1093/jnci/92.24.2009
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Platz, E. A.
Right arrow Articles by Giovannucci, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Platz, E. A.
Right arrow Articles by Giovannucci, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 24, 2009-2017, December 20, 2000
© 2000 Oxford University Press

Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals

Elizabeth A. Platz, Eric B. Rimm, Walter C. Willett, Philip W. Kantoff, Edward Giovannucci

Affiliations of authors: E. A. Platz, Department of Nutrition, Harvard School of Public Health, Boston, MA; E. B. Rimm, W. C. Willett, E. Giovannucci, Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, and the Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston; P. W. Kantoff, Lank Center for Genitourinary Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School.

Correspondence to present address: Elizabeth A. Platz, Sc.D., M.P.H., Department of Epidemiology, The Johns Hopkins School of Hygiene and Public Health, 615 N. Wolfe St., Baltimore, MD 21205 (e-mail: eplatz{at}jhsph.edu).

Background: Racial variation in prostate cancer incidence in the United States is pronounced, with African-American men having the highest rates. Whether differences in the distribution of known or suspected risk factors among racial groups explain this variation is unknown. Methods: We evaluated prospectively the relation between prostate cancer and race among 45 410 U.S. male health professionals aged 40–75 years in 1986. We used multivariable, pooled logistic regression to adjust the rate ratio (RR) for potential dietary and lifestyle risk factors. We also measured circulating levels of steroid hormones, sex hormone-binding globulin, and vitamin D metabolites and length of the androgen receptor gene CAG repeat in a sample of African-American (n = 43), Asian (n = 52), and white (n = 55) participants and assessed variation by race in these possible prostate epithelial cell growth mediators by use of analysis of variance. Statistical tests were two-sided. Results: The age-adjusted RR for prostate cancer was 1.73 (95% confidence interval [CI] = 1.23–2.45) for African-American men compared with white men. After multivariate adjustment, the RR increased to 1.81 (95% CI = 1.27–2.58). The rate of prostate cancer did not differ between Asians and whites. Steroid hormone and 1,25-dihydroxyvitamin D levels did not vary appreciably by race. However, the mean number of androgen receptor gene CAG repeats was lower among African-Americans (mean ± standard deviation = 20.1 ± 3.5) than among whites (22.1 ± 3.1; P = .007) and Asians (22.1 ± 3.9; P = .009). Conclusions: Our results confirm the elevated incidence of prostate cancer among African Americans and show that it is not explained by differences in the distribution of possible dietary and lifestyle risk factors in this cohort. Racial variation in length of the androgen receptor gene CAG repeat may explain a small part of the excess risk of prostate cancer among African-American men in this cohort.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. B. Araujo, T. G. Travison, B. Z. Leder, and J. B. McKinlay
Correlations between Serum Testosterone, Estradiol, and Sex Hormone-Binding Globulin and Bone Mineral Density in a Diverse Sample of Men
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2135 - 2141.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. Shah, H. J. Antoine, M. Pall, K. D. Taylor, R. Azziz, and M. O. Goodarzi
Association of Androgen Receptor CAG Repeat Polymorphism and Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1939 - 1945.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Sutcliffe, E. Giovannucci, C. A. Gaydos, R. P. Viscidi, F. J. Jenkins, J. M. Zenilman, L. P. Jacobson, A. M. De Marzo, W. C. Willett, and E. A. Platz
Plasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective Study
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1573 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Rohrmann, W. G. Nelson, N. Rifai, T. R. Brown, A. Dobs, N. Kanarek, J. D. Yager, and E. A. Platz
Serum Estrogen, But Not Testosterone, Levels Differ between Black and White Men in a Nationally Representative Sample of Americans
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2519 - 2525.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. P. Forman, E. Giovannucci, M. D. Holmes, H. A. Bischoff-Ferrari, S. S. Tworoger, W. C. Willett, and G. C. Curhan
Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension
Hypertension, May 1, 2007; 49(5): 1063 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Schildkraut, S. K. Murphy, R. T. Palmieri, E. Iversen, P. G. Moorman, Z. Huang, S. Halabi, B. Calingaert, A. Gusberg, J. R. Marks, et al.
Trinucleotide Repeat Polymorphisms in the Androgen Receptor Gene and Risk of Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 473 - 480.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B Lapauw, S Goemaere, P Crabbe, J M Kaufman, and J B Ruige
Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men?
Eur. J. Endocrinol., March 1, 2007; 156(3): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Giovannucci, Y. Liu, and W. C. Willett
Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2467 - 2472.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. J. Litman, S. Bhasin, C. L. Link, A. B. Araujo, J. B. McKinlay, and for the Boston Area Community Health Survey Invest
Serum Androgen Levels in Black, Hispanic, and White Men
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4326 - 4334.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. R. Rebbeck, C. H. Halbert, and P. Sankar
Genetics, Epidemiology, and Cancer Disparities: Is it Black and White?
J. Clin. Oncol., May 10, 2006; 24(14): 2164 - 2169.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Giovannucci, Y. Liu, E. B. Rimm, B. W. Hollis, C. S. Fuchs, M. J. Stampfer, and W. C. Willett
Prospective study of predictors of vitamin d status and cancer incidence and mortality in men.
J Natl Cancer Inst, April 5, 2006; 98(7): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Giovannucci, Y. Liu, M. J. Stampfer, and W. C. Willett
A prospective study of calcium intake and incident and fatal prostate cancer.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 203 - 210.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, R. Suk, G. Liu, S. Park, D. S. Neuberg, J. C. Wain, T. J. Lynch, E. Giovannucci, and D. C. Christiani
Vitamin D Is Associated with Improved Survival in Early-Stage Non-Small Cell Lung Cancer Patients
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2303 - 2309.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. A. Platz, M. F. Leitzmann, N. Rifai, P. W. Kantoff, Y.-C. Chen, M. J. Stampfer, W. C. Willett, and E. Giovannucci
Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1262 - 1269.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. L. Parnes, I. M. Thompson, and L. G. Ford
Prevention of Hormone-Related Cancers: Prostate Cancer
J. Clin. Oncol., January 10, 2005; 23(2): 368 - 377.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. M. Antoniucci, D. M. Black, and D. E. Sellmeyer
Serum 25-Hydroxyvitamin D Is Unaffected by Multiple Freeze-Thaw Cycles
Clin. Chem., January 1, 2005; 51(1): 258 - 261.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. P. Zeegers, L. A.L.M. Kiemeney, A. M. Nieder, and H. Ostrer
How Strong Is the Association Between CAG and GGN Repeat Length Polymorphisms in the Androgen Receptor Gene and Prostate Cancer Risk?
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1765 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
T. Gilligan, P. S. Wang, R. Levin, P. W. Kantoff, and J. Avorn
Racial Differences in Screening for Prostate Cancer in the Elderly
Arch Intern Med, September 27, 2004; 164(17): 1858 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al.
Structural and functional consequences of glutamine tract variation in the androgen receptor
Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci
Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Nowell, D. L. Ratnasinghe, C. B. Ambrosone, S. Williams, T. Teague-Ross, L. Trimble, G. Runnels, A. Carrol, B. Green, A. Stone, et al.
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Turner, A. J. Conway, M. Jimenez, P. Y. Liu, E. Forbes, R. I. McLachlan, and D. J. Handelsman
Contraceptive Efficacy of a Depot Progestin and Androgen Combination in Men
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4659 - 4667.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Drobnjak, J. Melamed, S. Taneja, K. Melzer, R. Wieczorek, B. Levinson, A. Zeleniuch-Jacquotte, D. Polsky, J. Ferrara, R. Perez-Soler, et al.
Altered Expression of p27 and Skp2 Proteins in Prostate Cancer of African-American Patients
Clin. Cancer Res., July 1, 2003; 9(7): 2613 - 2619.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Wu, S. J. Schwartz, E. A. Platz, S. K. Clinton, J. W. Erdman Jr., M. G. Ferruzzi, W. C. Willett, and E. L. Giovannucci
Variations in Plasma Lycopene and Specific Isomers over Time in a Cohort of U.S. Men
J. Nutr., June 1, 2003; 133(6): 1930 - 1936.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Zitzmann, M. Depenbusch, J. Gromoll, and E. Nieschlag
Prostate Volume and Growth in Testosterone-Substituted Hypogonadal Men Are Dependent on the CAG Repeat Polymorphism of the Androgen Receptor Gene: A Longitudinal Pharmacogenetic Study
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2049 - 2054.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. N. Ames
The Metabolic Tune-Up: Metabolic Harmony and Disease Prevention
J. Nutr., May 1, 2003; 133(5): 1544S - 1548.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis
Association of the CYP17 Gene Polymorphism with the Risk of Prostate Cancer: A Meta-Analysis
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 120 - 126.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. M. Gapstur, P. H. Gann, P. Kopp, L. Colangelo, C. Longcope, and K. Liu
Serum Androgen Concentrations in Young Men: A Longitudinal Analysis of Associations with Age, Obesity, and Race. : The CARDIA Male Hormone Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1041 - 1047.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. L. Bennett, D. K. Price, S. Kim, D. Liu, B. D. Jovanovic, D. Nathan, M. E. Johnson, J. S. Montgomery, K. Cude, J. C. Brockbank, et al.
Racial Variation in CAG Repeat Lengths Within the Androgen Receptor Gene Among Prostate Cancer Patients of Lower Socioeconomic Status
J. Clin. Oncol., September 1, 2002; 20(17): 3599 - 3604.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. G. Bacon, F. B. Hu, E. Giovannucci, D. B. Glasser, M. A. Mittleman, and E. B. Rimm
Association of Type and Duration of Diabetes With Erectile Dysfunction in a Large Cohort of Men
Diabetes Care, August 1, 2002; 25(8): 1458 - 1463.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. L. Grover and F. L. Martin
The initiation of breast and prostate cancer
Carcinogenesis, July 1, 2002; 23(7): 1095 - 1102.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Zitzmann, M. Brune, B. Kornmann, J. Gromoll, S. von Eckardstein, A. von Eckardstein, and E. Nieschlag
The CAG Repeat Polymorphism in the AR Gene Affects High Density Lipoprotein Cholesterol and Arterial Vasoreactivity
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4867 - 4873.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.